IP Library Granted Patent US 8,501,934
Granted Patent B2
US 8,501,934 · App. 13/055,194 · Granted Aug 6, 2013

Pyrrolobenzodiazepines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,934
App. No.
13/055,194
Granted
Aug 6, 2013
Kind
B2
Abstract

Methods of preparing ZC-423 (I) which result in varying enantiomeric ratios.

Claims (22)

1. A method of preparing ZC-423:

the method comprising the step of treating compound (14):

with a biphasic solvent mixture comprising sodium bisulphite, wherein the biphasic solvent mixture comprises an aqueous solution of the bisulphite salt and an organic solvent that is immiscible with the aqueous solution, and compound (14) is treated with the bisulphite salt for 12 hours or more.

2. The method of claim 1 , wherein the organic solvent is a solvent that dissolves compound (14).

3. The method of claim 2 , wherein the organic solvent is DCM.

4. The method of claim 1 , wherein compound (14) is treated with the bisulphite salt for 24 hours or more.

5. The method of claim 1 wherein the product of the reaction is frozen soon after the reaction is deemed complete.

6. The method of claim 5 , wherein in the product of the reaction is frozen to a temperature of −100° C. or below.

7. The method of claim 6 , wherein in the product of the reaction is frozen to a temperature of −190° C. or below.

8. The method of claim 5 further comprising the step of freeze-drying the product after the product is frozen.

9. Compound ZC-423 comprising 70% or more of the S,R-diastereomer.

10. A method of preparing ZC-423:

the method comprising the step of treating compound (14)

with a solvent mixture comprising sodium bisulphite, wherein the solvent mixture comprises an aqueous solution of the bisulphite salt and an organic solvent that is miscible with the aqueous solution.

11. The method of claim 10 , wherein the organic solvent is an alkyl alcohol.

12. The method of claim 11 , wherein the alkyl alcohol is propyl alcohol.

13. The method of claim 11 , wherein the propyl alcohol is isopropylalcohol (IPA).

14. The method of claim 10 , wherein the product of the reaction is frozen soon after the reaction is deemed complete.

15. The method of claim 14 , wherein in the product of the reaction is frozen to a temperature of −100° C. or below.

16. The method of claim 15 , wherein in the product of the reaction is frozen to a temperature of −190° C. or below.

17. The method of claim 14 further comprising the step of freeze-drying the product after the product is frozen.

18. Compound ZC-423 comprising 70% or more of the S,S-diastereomer.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE POSTAL CODE OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036932 FRAME: 0278. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Apr 11, 2017
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 042242/0389 →
CONFIRMATORY ASSIGNMENT Recorded Oct 23, 2015
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 036932/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2013
From: SPIROGEN LIMITED
To: SPIROGEN DEVELOPMENTS SARL
Reel/Frame 030326/0354 →
MERGER Recorded May 1, 2013
From: SPIROGEN DEVELOPMENTS SARL
To: SPIROGEN SARL
Reel/Frame 030326/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2011
From: HOWARD, PHILIP WILSON; GREGSON, STEPHEN JOHN; CHEN, ZHIZHI; TIBERGHIEN, ARNAUD CHARLES; MASTERSON, LUKE
To: SPIROGEN LIMITED
Reel/Frame 025684/0145 →